Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

988
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
988
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

9.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

908
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
908
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

4.6K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The plant hormone, 6-benzylaminopurine, ameliorates obesity in male and female mice while on a high-fat diet.

Molecular metabolism·2026
Same author

Microbial 10-oxostearic acid protects mice against colitis via the nuclear receptor PPARα.

Nature microbiology·2026
Same author

A Cationic Amphiphilic Drug (CAD) Defense System in the Nematode <i>Caenorhabditis elegans</i>.

bioRxiv : the preprint server for biology·2026
Same author

MetaboMiNR: An Online Tool to Analyze Label-Free Proteomic Experiments With a Focus on Metabolism and Nuclear Receptors.

Endocrinology·2025
Same author

Hepatic p38α at the forefront of diet-induced insulin resistance and hepatic steatosis.

American journal of physiology. Endocrinology and metabolism·2025
Same author

CES1 Increases Hepatic Triacylglycerol Synthesis Through Activation of PPARγ, LXR and SREBP1c.

Cells·2025

Related Experiment Video

Updated: Apr 14, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.2K

Glucocorticoids and Metabolic Control.

Lilia Magomedova1, Carolyn L Cummins2

  • 1Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, M5S 3M2, Canada.

Handbook of Experimental Pharmacology
|April 29, 2015
PubMed
Summary

Glucocorticoids (GCs) are vital for energy balance but excessive levels cause metabolic dysfunction. This review details GCs' roles in glucose, lipid, and protein metabolism and their dysregulation.

Keywords:
Adipose tissueGlucocorticoid hormonesGlucocorticoid receptorGluconeogenesisLipid metabolismLiverMuscleProtein metabolism

More Related Videos

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.4K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

72.7K

Related Experiment Videos

Last Updated: Apr 14, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

96.2K
Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
07:35

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

2.4K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

72.7K

Area of Science:

  • Endocrinology
  • Metabolic Science
  • Neuroendocrinology

Background:

  • The central nervous system releases glucocorticoids (GCs) under stress to maintain energy homeostasis.
  • GCs, acting via the glucocorticoid receptor (GR), mobilize energy stores, ensuring glucose supply for the brain.
  • While essential, chronic overexposure to GCs results in detrimental metabolic effects.

Purpose of the Study:

  • To summarize the multifaceted metabolic functions of glucocorticoids.
  • To elucidate the mechanisms of glucocorticoid dysregulation in metabolic disorders.
  • To focus on the impact of GCs on glucose, lipid, and protein metabolism.

Main Methods:

  • Literature review of studies on glucocorticoid metabolism.
  • Analysis of signaling pathways involving the glucocorticoid receptor.
  • Synthesis of data on metabolic consequences of GC excess.

Main Results:

  • GCs play a critical role in regulating glucose, lipid, and protein metabolism.
  • Excessive GC activity leads to hyperglycemia, insulin resistance, and fatty liver.
  • Chronic GC stimulation contributes to obesity and muscle wasting, indicating severe metabolic dysfunction.

Conclusions:

  • Glucocorticoids are key regulators of energy homeostasis.
  • Dysregulation of GC signaling contributes significantly to metabolic syndrome.
  • Understanding GC metabolism is crucial for addressing metabolic diseases.